Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 556, pseudogene (RN7SL556P) is classified as a pseudogene of the 7SL RNA, which is the RNA component of the signal recognition particle (SRP) that plays an essential role in directing newly synthesized proteins to the endoplasmic reticulum in eukaryotic cells[1][3][5][6]. However, RN7SL556P itself is not a protein-coding gene, nor is it known to be functional or expressed as a physiologically relevant molecule; like other 7SL pseudogenes, it is thought to be a truncated, non-functional copy resulting from retrotransposition or duplicative events[1][6]. There is currently no evidence that this pseudogene acts as a therapeutic target, participates directly in biological processes, or is associated with disease, drug interaction, or use as a biomarker. Its primary relevance is as a genomic sequence homologous to the functional 7SL RNA gene, and it is predominantly referenced in genomic annotation and pseudogene catalogs[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 556, pseudogene (RN7SL556P).